Once again the nathsayers come out to play
Well I could say the following
Merck could put multiple drugs in trials using our platform
Genentech could put multiple drugs in trials using our platform
Chase Sun could put multiple drugs in trials using our platform
Dep Cabazitaxel could be licensed out to big pharma
Dep Docetaxel could be licensed out to big pharma
Dep Irinotecan could be licensed out to big pharma
SPL7013 marketed products could start generating good revenue
Preclinical drugs ready to go into trials could be licensed out to big pharma
We are now a mature company with proof of concept throughout all our in house drugs
There is no way this company is going anywhere except up in my opinion
Esmer is a non holder
AHS is a non holder
Teddyward is a non holder
WBA is a non holder
And guess what..........all spinning the same negative stories
- Forums
- ASX - By Stock
- SPL
- Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-94
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
10.0¢ |
Change
0.002(2.04%) |
Mkt cap ! $41.73M |
Open | High | Low | Value | Volume |
9.9¢ | 10.5¢ | 9.9¢ | $49.15K | 486.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 65751 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 226460 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 65751 | 0.100 |
2 | 107649 | 0.099 |
1 | 300000 | 0.098 |
2 | 45155 | 0.097 |
2 | 100000 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 226460 | 3 |
0.110 | 240068 | 5 |
0.115 | 109827 | 3 |
0.120 | 63057 | 7 |
0.125 | 80424 | 5 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |